Peng benzathine/procaine inj
Products billed under this code include Bicillin CR.
Payment limit per 100,000 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Bicillin CR.
Payment limit per 100,000 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Bicillin CR | Pfizer Inc | 60793-0600-10 | 120 | $2,342.76 |
| Bicillin CR | Pfizer Inc | 60793-0601-10 | 120 | $2,342.76 |
| Bicillin CR | Pfizer Inc | 60793-0602-10 | 120 | $2,342.76 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted September 17, 2026 |
| 3Q26 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted September 15, 2026 |
| 2Q26 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted September 15, 2026 |
| 1Q26 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted September 15, 2026 |
| 4Q25 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted September 8, 2026 |
| 3Q25 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted March 10, 2026 |
| 2Q25 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted March 10, 2026 |
| 1Q25 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted December 19, 2025 |
| 4Q24 | $19.523 | $0.00 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 11, 2025 |
| 3Q24 | $19.523 | +$2.155 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 11, 2025 |
| 2Q24 | $17.368 | −$0.21 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted March 11, 2025 |
| 1Q24 | $17.578 | +$1.836 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted December 19, 2024 |
| 4Q23 | $15.742 | +$0.069 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted October 10, 2024 |
| 3Q23 | $15.673 | +$1.257 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 5, 2024 |
| 2Q23 | $14.416 | +$0.536 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted February 23, 2024 |
| 1Q23 | $13.88 | +$0.707 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted December 6, 2023 |
| 4Q22 | $13.173 | +$0.312 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 22, 2023 |
| 3Q22 | $12.861 | +$1.079 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 9, 2023 |
| 2Q22 | $11.782 | +$0.006 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted December 14, 2022 |
| 1Q22 | $11.776 | −$0.011 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 8, 2022 |
| 4Q21 | $11.787 | −$0.254 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 2, 2022 |
| 3Q21 | $12.041 | −$0.016 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted June 2, 2022 |
| 2Q21 | $12.057 | +$0.049 | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted March 1, 2022 |
| 1Q21 | $12.008 | – | 100,000 UNITS | Peng benzathine/procaine inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.